A New Way Forward in Ovarian Cancer: Why Synthetic iMSCs Could Change the Paradigm - Pharmaceutical Technology

Synthetic Induced Mesenchymal Stem Cells Being Studied as Potential Treatment for Recurrent Ovarian Cancer

Ovarian cancer remains one of the most difficult cancer […] The post Synthetic Induced Mesenchymal Stem Cells Being Studied as Potential Treatment for Recurrent Ovarian Cancer first appeared on GeneOnline News. The post Synthetic Induced Mesenchymal Stem Cells Being Studied as Potential Treatment for Recurrent Ovarian Cancer appeared first on GeneOnline News.

A new way forward in ovarian cancer: why synthetic iMSCs could change the paradigm - Pharmaceutical Technology

Ovarian cancer is one of the most challenging malignancies in oncology. Despite advances in diagnosis and treatment, it is still the deadliest gynaecologic cancer, claiming about 13,000 U.S. lives each year. In far too many patients, the story is heartbreakingly familiar: an initial response to platinum-based chemotherapy is followed by recurrence within one or two years, leaving fewer and less effective treatment options available.